Rui-Ping Dong

473 citations
18 papers · 358 indexed · h-index 10
Topics
CAR-T cell therapy research (3 papers)Cancer Immunotherapy and Biomarkers (3 papers)Immunodeficiency and Autoimmune Disorders (2 papers)
Partner nations
ChinaJapanUnited States

In The Last Decade

Rui-Ping Dong

18 papers receiving 352 citations

Peers

Rui-Ping Dong
Comparison fields: 5 of 67
  • Molecular Biology 150
  • Oncology 136
  • Immunology 84
  • Pulmonary and Respiratory Medicine 62
  • Hematology 39
Replace Sandra Sapia with:
Sandra Sapia Argentina
H Zhuang United States
Steve De Vos Belgium
László Márkász Sweden
Xiaoxiao Zuo China
Suyu Miao China
K Käppler United States
Yang Mh Taiwan
Chia-Li Yu Taiwan
Rui-Ping Dong relative to Sandra Sapia Argentina Sandra Sapia's profile →
Citations per field
00.5×3.7×
Sandra Sapia · 1×
Citations per year

Countries citing papers authored by Rui-Ping Dong

Since Specialization
Citations

This map shows the geographic impact of Rui-Ping Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui-Ping Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui-Ping Dong more than expected).

Fields of papers citing papers by Rui-Ping Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui-Ping Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui-Ping Dong. The network helps show where Rui-Ping Dong may publish in the future.

Co-authorship network of co-authors of Rui-Ping Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Rui-Ping Dong. A scholar is included among the top collaborators of Rui-Ping Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui-Ping Dong. Rui-Ping Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 7
2 1
3 3
4 53
5 3
6 5
7 9
8 2
9
[Polymorphism of human killer cell immunoglobulin-like receptor gene in Chinese Jiangsu Han population].
2
10 60
11 2
12 17
13 72
14 16
15 17
16 42
17 33
18 14

About Rui-Ping Dong

Rui-Ping Dong is a scholar working on Immunology, Oncology and Hematology, having authored 18 papers that have together received 358 indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Oncology (136 citations), Immunology (84 citations) and Hematology (39 citations). Rui-Ping Dong has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Stuart F. Schlossman, Chonghui Zhang, Jijie Gu, Hajime Tamai, Akinori Kimura, Mei X. Wu, Daniel F. McLaughlin, Deborah Marcellus, Sarah Mathews and Donna Reece. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026